Filter by: Subject

Results Per Page:

Filter by: Subject

5-lipoxygenase (1)
Active pulmonary tuberculosis (1)
Acute cardiac events (1)
Acute cardiovascular event (ACE) (1)
Acute phase response (1)
Adenosine 50-diphosphate (1)
Adhesins (2)
Adjunctive therapy (1)
Adjuvant therapy (1)
Airway epithelial cells (1)
Angiogenesis (1)
Anti-inflammatory (1)
Anti-inflammatory activity (1)
Anti-inflammatory properties (1)
Antibacterial therapy (1)
Antibiotic properties (1)
Antibiotic resistance (1)
Antibiotics (3)
Antimicrobial activities (1)
Antiretroviral therapy (ART) (1)
Aspirin (1)
Bacteremic (1)
Bacterial cause (1)
Benefits (1)
Beta-2-adrenoreceptor agonists (1)
Biofilm formation (1)
Biomarker (1)
Biomarkers (3)
Burden of disease (1)
C-Reactive protein (1)
C-Reactive protein (CRP) (1)
Calcium (5)
Calcium ionophore (1)
Carbon monoxide (CO) (1)
Cardiac complications (1)
Cardiac events (1)
Cardiac troponin T (1)
Cardiovascular event (CVE) (1)
Cardiovascular events (1)
Catecholamines (2)
CD25 (1)
CD4 cell count (1)
CD62P (1)
Chemokines (1)
Cholesterol-dependent cytolysins (1)
Chronic granulomatous disease (1)
Chronic obstructive pulmonary disease (1)
Cigarette smoke condensate (1)
Clarithromycin (1)
Clofazimine (1)
Combination antiretroviral therapy (cART) (1)
Community-acquired bacterial pneumonia (1)
Community-acquired pneumonia (5)
Community-acquired pneumonia (CAP) (1)
Community-acquired pneumonia (CAP) (9)
Conversion (1)
Corticosteroids (2)
Corticosteroids (CS) (1)
Cortisol (1)
Culture (1)
CURB-65 (1)
Cyclic AMP (1)
Cyclic nucleotide phospodiesterase (1)
CysLT receptor-1 (cysLTR1) (1)
CysLTR1 receptor antagonists (1)
CysLTR1-independent anti-Inflammatory mechanisms (1)
Cysteinyl leukotrienes (1)
Cysteinyl leukotrienes (cysLTs) (1)
Cystic fibrosis (1)
Cytokines (1)
Depletion (1)
Doxycycline (1)
Drug resistance (1)
Elastase (1)
Exercise-induced asthma -- Treatment (1)
Exposure of a 23F serotype strain (1)
Fatty acid-binding proteins (1)
Ferritin (1)
Floroquinolones (1)
Fluoroquinolones (1)
Formoterol (1)
General population (1)
Harms (1)
Healthcare providers (1)
Highly active antiretroviral therapy (HAART) (1)
Histone acetyltransferase (1)
HIV infection (1)
HIV pandemic (1)
HIV-infected persons (1)
HIV-positive patients (1)
HIV-positive persons -- Tobacco use (1)
Host defences (1)
Host defenses (1)
Host innate immune system (1)
Human immunodeficiency virus (HIV) (4)
Human neutrophils in vitro (1)
Hydrogen peroxide (3)
Imidazole anti-mycotics (1)
Immune activation (1)
Immune system (1)